This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

All pretty quiet, eh?
I see the sp is limping along at 20p-ish.
Is there a "strategic review" in progress?

-OR-
What Next?

It was only a few months ago this stock was over 1, representing an 80% loss. I'm guessing they will increase the shares with a Placing, to improve the holding-power of the Institutional investors. This might be one way to reduce the Voting-power of the Bests.

Over 12 months ago they knew Cash was running out - but I guess D.B was "hopeful" something would turn-up. Unfortunately he had no fall-back position and no "deal" materialised.
FWIW... as I see it, the 3-platforms aren't worth much, as they aren't very far along the Phase-trials.....although they have had lots of investor-money spent - in the main, it seems it was salaries to the Bests . . . . . . . oh deary!

EDIT Aug08-
Down to 12p although a recent "review" was as upbeat as situation allowed and Prudential increased their stake. If there is a Placing, it will be at pennies and Loyal Punters will be severely diluted as many paid 1 +
EDIT 02Sept08-
Down to 11/12p (-8%), on zero volume so far. Placing at 5p maybe soon?

Game over it seems.............

Money is too tight to mention never mind with MMG.

Bad luck guys.

Hi hangon what are your thoughts here bearing in mind the current price and that biotech is out of favor at the moment

Now MOVING up.

And down again.

End of the road soon.

FWIW the issue is the previous Exec shareholding.
Unfortunately the law allows ex-execs to shackle the reigning Execs, by blocking votes and so on.
This is not in the interest of shareholders who bought on the open market and should be made illegal.
The shareholding is considerably less valuable that earlier, due to their lack of stewardship (and maybe other reasons) so by any logic they are feeling considerable pain as the shares slip.

They are hoping to revive the company and maybe return to the fold, but I suspect the real value is lacking and this business is unfit for purpose as structured. The proposed change of name to OncoScience is also a very poor choice, although it is almost at zero-cost.

I suspect this will fall further as mitzy suggests, there being no future until the share-ownership (problem) is removed.
Any other views?

Agree there hangon the company is going nowhere until the Bests shareholding position is resolved..I'm not holding my breath.

Seems outrageous to me that a relatively small holder ( esp one running the business for much of the failing Mkt cap) -can effectivly create a stalemate, until their demands are met ( my words)....whatever they are, eh?
Seems to me the Co needs to go to the High Court and get a ruling that allows progress without fearing a block-vote from the Bests.
Alternatively the Court might put a value on the Bests' holding as if nothing is done, based on the falling SP over the last few months.
Given that "doing nothing" will effectivly kill the business, it's about time the Bests bowed-out and took a relativly small % so that other investors can get on with the Business.
FWIW I suggest total take up of 9% of the new company, or 10% if the shares are stripped of their voting-rights. (Upon sale, the voting rights would be restored)
Frankly, considering the buiness is worth sod-all (now), that's a pretty good offer if the business survives, but the longer this goes on the greater the risk it will fail all-together.
(Bests had their turn for 10+ years and look at the results - it's barely further ahead that at the start.....and the cash is all spent, mostly on the Bests' income )

!!!.What a waste of time and (retail-)shareholder-money.!!!

Grr.

EDIT: It seems just one day later (30Sept, see RNS) MMG has done a deal over their research centre in Cambridge, in effect a large millstone has been replaced by two smaller millstones, with payments of 100k right now and another 100k in 2009.....ooer, I wonder if there are other Lock-in problems created by the previous Management?....all this adds up to woeful business activity.
All IMHO, DYOR, this is not a clear story.

I have placed a limit order @3p.

Attention:

Nearly 1 mill shares traded today...

.......

gf you in...?

Heard gf had retired

Sorry to hear that....I wonder if he still holds..?

HI THERE. I HAVE DECIDED GIVE SOME ADVICE WHICH IS RARE I JUST VOICE THINGS BUT DON'T OFFER ADVICE. OKAY THE PRICE OF THE FTSE IS APPROX 4100 RIGHT NOW AND YES IT COULD HIT 2700'S BUT IF YOU HAVE ENOUGH MONEY TO COVER TO ZERO SO 4000 AT 1 PER POINT WILL COVER EVERYTHING AND YOU WILL STILL GET SOME INTEREST FOR HOLDING SHORT IF IT GOES TO ZERO. YOU UNDERSTAND WHAT I MEAN. THE FTSE WILL NOT DISAPPEAR UNLESS MANKIND DISAPPEARS TOO. SO IF YOU BUY NOW OR LOWER AND HOLD FOR THE FUTURE, YOU CAN SECURE A TIDY NEST EGG FOR YOUR CHILDREN YOURSELF OR WHATEVER. IT WILL GO BACK UP FOR SURE JUST DON'T GET TOO GREEDY AND OVERSTRETCH YOURSELF.

I have placed a buy order at 2p.

You never know do you its a gamble at the moment could lose or double my money.

until the ownership problem is solved this will continue to fall...

mitzy - yea I agree, it must like watching their house burn down.
Can't they understand they have lost it and try to salvage some dignity and maybe . . . .
It is crazy that the Law allows this distruction of Value by disgraced Directors.
(Not that I ever believed their story, from day one; it was too good to be true.)


HiThere - I'm not sure I follow your suggestion...at 1 per point, if the FTSE rises to 6000, you make a little under 3k - which is hardly a fortune ( although welcome, ), however, the chances of FTSE hittinig 6000 is almost zero in the next two years - and the risk of reaching 0 is EVEN less likely, IMHO. Furthermore if the FTSE fell below 1000, I suspect you'd find it difficult to contact your broker, so I guess your Bet is over and out even if it then rose to 6000.
Don't these "bets" have a Time-element also, so they last maybe 3-months and then you have to re-negotiate, etc.?

Important rns out today could prove the tipping point lets wait and see.

MMI advances prostrate cancer clinical trials

Written by Lautaro Vargas
Friday, 13 March 2009

Cancer drug developer, Medical Marketing International (MMI), is pushing forwards with plans to take its commercial prostate cancer vaccine (GVX 3322) into Phase II clinical trials following the successful completion of preclinical equivalence studies.

The Cambridge companys share price rose 6.1 per cent to 6.5p a share following the announcement that it is now in discussions with leading clinical oncologists to define the key parameters for a prostate cancer trial.

MMIs chemotherapy work has also advanced significantly, with pre-clinical studies on how its ruthenium compound ONCO 4417 kills cancer cells hinting that a number of novel cancer targets may be possible.

http://www.businessweekly.co.uk/2009031334670/life-sciences/mmi-advances-prostrate-cancer-clinical-trials.html